Effectiveness of initiating biologics in severe asthma patients with high steroid exposure

W. Chen (Singapore , Singapore), T. N Tran (Gaithersburg, United States), M. Sadatsafavi (Vancouver, Canada), E. Garcia Gil (Barcelona, Spain), M. Alacqua (Milan, Italy), A. Menzies Gow (London, United Kingdom), L. G Heaney (Belfast, United Kingdom), P. E.Pfeffer (London, United Kingdom), J. Maspero (Buenos Aires , Argentina), M. Peters (Sydney, Australia), G. C Christoff (Sofia , Bulgaria), M. Bhutani (Alberta, Canada), C. A.Torres-Duque (Bogotá, Colombia), C. Ulrik (Hvidovre, Denmark), A. Altraja (Tartu , Estonia), L. Lehtimaki (Tampere, Finland), C. Taille (Paris, France), A. I.Papaioannou (Athens, Greece), S. Salvi (Pune, India), R. W Costello (Dublin, Ireland), G. Walter Canonica (Milan , Italy), T. Iwanaga (Osakasayama, Japan), M. Al-Ahmad (Kuwait , Kuwait), D. Larenas-Linnemann (Ciudad de México, Mexico), P. Kuna (Lódz, Poland), J. A.Fonseca (Porto, Portugal), R. Al-Lehebi (Riyadh, Saudi Arabia), M. Koh Siyue (Singapore, Singapore), C. Rhee (Seoul, Republic of Korea), L. Perez-De-Llano (Lugo, Spain), R. C Jones (Plymouth, United Kingdom), D. Perng (Taipei, Taiwan), E. Wang (Denver, United States), F. Hoyte (Denver, United States), N. Wong Chong Boon (Singapore , Singapore), J. Lyu (Singapore , Singapore), C. Ariti (Singapore , Singapore), R. Murray (Singapore , Singapore), C. Goh (Singapore , Singapore), I. Joshi (Singapore , Singapore), N. Eleangovan (Singapore , Singapore), D. Price (Singapore , Singapore)

Source: International Congress 2022 – Asthma treatment: real-world studies and other diseases

Session: Asthma treatment: real-world studies and other diseases
Session type: Thematic Poster
Number: 1330

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Chen (Singapore , Singapore), T. N Tran (Gaithersburg, United States), M. Sadatsafavi (Vancouver, Canada), E. Garcia Gil (Barcelona, Spain), M. Alacqua (Milan, Italy), A. Menzies Gow (London, United Kingdom), L. G Heaney (Belfast, United Kingdom), P. E.Pfeffer (London, United Kingdom), J. Maspero (Buenos Aires , Argentina), M. Peters (Sydney, Australia), G. C Christoff (Sofia , Bulgaria), M. Bhutani (Alberta, Canada), C. A.Torres-Duque (Bogotá, Colombia), C. Ulrik (Hvidovre, Denmark), A. Altraja (Tartu , Estonia), L. Lehtimaki (Tampere, Finland), C. Taille (Paris, France), A. I.Papaioannou (Athens, Greece), S. Salvi (Pune, India), R. W Costello (Dublin, Ireland), G. Walter Canonica (Milan , Italy), T. Iwanaga (Osakasayama, Japan), M. Al-Ahmad (Kuwait , Kuwait), D. Larenas-Linnemann (Ciudad de México, Mexico), P. Kuna (Lódz, Poland), J. A.Fonseca (Porto, Portugal), R. Al-Lehebi (Riyadh, Saudi Arabia), M. Koh Siyue (Singapore, Singapore), C. Rhee (Seoul, Republic of Korea), L. Perez-De-Llano (Lugo, Spain), R. C Jones (Plymouth, United Kingdom), D. Perng (Taipei, Taiwan), E. Wang (Denver, United States), F. Hoyte (Denver, United States), N. Wong Chong Boon (Singapore , Singapore), J. Lyu (Singapore , Singapore), C. Ariti (Singapore , Singapore), R. Murray (Singapore , Singapore), C. Goh (Singapore , Singapore), I. Joshi (Singapore , Singapore), N. Eleangovan (Singapore , Singapore), D. Price (Singapore , Singapore). Effectiveness of initiating biologics in severe asthma patients with high steroid exposure. 1330

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.